Insiders Immatics N.V.

Equities

IMTX

NL0015285941

Market Closed - Nasdaq Other stock markets 21:00:00 16/05/2024 BST			5-day change	1st Jan Change
10.81 ^USD	-2.44%		+1.60%	+2.66%

05-15	Mizuho Raises Immatics' Price Target to $16 From $14, Keeps Buy Rating	MT
05-14	Immatics' Q1 Loss Narrows. Revenue Rises	MT

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Immatics N.V. Appoints M.P. Hothum as Non-Executive Director Class III	20/06/23	CI
Immatics N.V. Appoints Biotech Executive Eliot Forster to Board of Directors	15/09/20	CI
Immatics Biotechnologies Gmbh Announces Management Changes	04/06/20	CI
Immatics biotechnologies GmbH Appoints Harpreet Singh as Chief Executive Officer	08/07/19	CI
Immatics Appoints Thomas Ulmer as Chief Financial Officer, Effective April 1, 2018	21/02/18	CI
Immatics Biotechnologies GmbH Appoints Katina Dorton as Chief Financial Officer	08/01/16	CI
Immatics Biotechnologies GmbH Announces Changes to its Board	12/11/12	CI
Immatics Biotechnologies GmbH Appoints Rainer Kramer as Chief Business Officer	19/04/12	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Like the pros, access all the transcripts and spot the best opportunities before anyone else.

Unlock them now!

fermer